Corrigendum to “E1K, a disease-modifying drug candidate for knee osteoarthritis, alleviates pain and regenerates cartilage simultaneously by inhibiting TGF-β1-mediated SMAD1/5/9 signaling in osteoarthritis models” [<strong>Osteoarthr. Cartil.</strong> 34…
Publication date: April 2026
Source: Osteoarthritis and Cartilage, Volume 34, Issue 4
Author(s): Eun-Joung Moon, Ji Ae Kim, Yunsil Jang, Hyeon-Jeong Kim, Sang-Je Park, Cheolmin Lee, Nam Sook Kang, Hae-Jin Kim